10-Propargyl-10-Deazaaminopterin in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma
Clinical trial NCT00052442 · COMPLETED
Trial details
- NCT number
- NCT00052442
- Sponsor
- Spectrum Pharmaceuticals, Inc
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-08-01
- Primary completion
- 2009-03-01
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.